Schizophrenia Spectrum and Other Psychotic Disorders Clinical Trials
2 recruiting trials for Schizophrenia Spectrum and Other Psychotic Disorders. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Schizophrenia Spectrum and Other Psychotic Disorders clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Bjorn H. Ebdrup (1), Central South University (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Treatment in the Meta Care Clinic (other, 1 trial), followed by Standard care with general practitioner and/or outpatient clinics, Regular follow-up assessments without intervention..
Track Schizophrenia Spectrum and Other Psychotic Disorders trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Effectiveness of a Pragmatic, Metabolic Care Clinic for Patients With Severe Mental Illness - The Meta Care Clinic
This study will examine the effectiveness of a Pragmatic, Metabolic Care Clinic for Patients With Severe Mental Illness
Immunoinflammatory State Detection and Multimodal Brain Imaging and Electrophysiologic Changes in Schizophrenia
Schizophrenia is a severe mental illness that seriously affects the health and functioning of patients. Previous studies have found immunoinflammatory abnormalities in the blood,...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Schizophrenia Spectrum and Other Psychotic Disorders, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Schizophrenia Spectrum and Other Psychotic Disorders, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Schizophrenia Spectrum and Other Psychotic Disorders, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.